Utilization of Intravenous Ribavirin Among Reproductive Age Adults in 2010–2017: A Population-Based Study in the Yinzhou District, Ningbo City of China

Utilization of Intravenous Ribavirin Among Reproductive Age Adults in 2010–2017: A Population-Based Study in the Yinzhou District, Ningbo City of China

Background: Intravenous (IV) ribavirin is not approved in US and European Union, but it is authorized in China. Significant teratogenic and embryocidal effects of ribavirin have been found in almost all animal studies, it is critical to investigate the prevalence and trends of the utilization of IV...

Full description

Bibliographic Details
Main Authors: Hailong Li, Houyu Zhao, Hongbo Lin, Peng Shen, Cuili Liu, Siyan Zhan
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Public Health
Subjects:
intravenous ribavirin
reproductive age
drug utilization
rational drug use
population-based study
Online Access:https://www.frontiersin.org/articles/10.3389/fpubh.2021.678785/full

Internet

https://www.frontiersin.org/articles/10.3389/fpubh.2021.678785/full

Similar Items